Revenues Not Telling The Story For Hangzhou Alltest Biotech Co., Ltd. (SHSE:688606)

It's not a stretch to say that Hangzhou Alltest Biotech Co., Ltd.'s (SHSE:688606) price-to-sales (or "P/S") ratio of 6.5x seems quite "middle-of-the-road" for Medical Equipment companies in China, se

Simply Wall StApr 8 03:04 ET

Aotai Biotech (688606.SH): The ban on 2.092,900 restricted shares was lifted on March 25

Gelonghui March 14 | Aotai Biotech (688606.SH) announced that the total number of shares in circulation during the current stock listing of the company is 2.092,900 shares. The stock listing and circulation date is March 25, 2024.

Gelonghui FinanceMar 14 05:28 ET

Is Hangzhou Alltest Biotech Co., Ltd.'s (SHSE:688606) Stock Price Struggling As A Result Of Its Mixed Financials?

With its stock down 20% over the past three months, it is easy to disregard Hangzhou Alltest Biotech (SHSE:688606). It is possible that the markets have ignored the company's differing financials an

Simply Wall StFeb 29 18:21 ET

Aotai Biotech (688606.SH) completed the repurchase and spent 595.75,500 yuan to repurchase 1.03 million shares

Aotai Biotech (688606.SH) announced that the company has completed the repurchase and has actually repurchased 1.03 million shares of the company's shares, accounting for...

Zhitong FinanceFeb 23 04:18 ET

Aotai Biotech (688606.SH)'s net profit for 2023 was 180 million yuan, a sharp decrease of 84.8%

Aotai Biotech (688606.SH) disclosed the 2023 annual results report, and the company achieved a total operating revenue of 7.55...

Zhitong FinanceFeb 23 04:15 ET

Aotai Biotech (688606.SH): It spent 53.432 million yuan to buy back a total of 1.1651% of the shares

Gelonghui, January 31, 丨 Aotai Biotech (688606.SH) announced that as of January 31, 2024, the company had repurchased a total of 923,700 shares of the company's shares through centralized bidding transactions, accounting for 1.1651% of the company's total share capital of 79,280,855 shares, an increase of 0.6606% compared with the previous disclosure. The highest price of the repurchase transaction was 60.00 yuan/share, the lowest price was 55.11 yuan/share, and the total capital paid was RMB 53.432 million (excluding stamp duty, transaction commissions, etc.) transaction fees).

Gelonghui FinanceJan 31 03:36 ET